BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9007963)

  • 1. Massive amyloid deposition in pancreatic vipoma: a case report.
    Crowley PF; Slavin JL; Rode J
    Pathology; 1996 Nov; 28(4):377-9. PubMed ID: 9007963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VIPoma of pancreas in a child.
    Samal SC; Paul AC; Venkateswari S; Nair S; Venkatramani S; Perakath B; Simon A; Chandy G; Kurian G
    Indian J Gastroenterol; 2000; 19(4):194-5. PubMed ID: 11059195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal polypeptide-secreting tumours (vipomas) in childhood.
    Long RG
    J Pediatr Gastroenterol Nutr; 1983; 2(1):122-6. PubMed ID: 6310076
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pancreatic vipoma with bizarre characteristics].
    Bermejo F; Moreno L; Moreira V; Gisbert JP; González Palacios F; García López JL
    Gastroenterol Hepatol; 1999 Mar; 22(3):132-5. PubMed ID: 10228323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are pancreatic VIPomas paraneuron neoplasms? A clue to the neuroectodermal origin of these tumors.
    Bani Sacchi T; Bani D; Biliotti G
    Pancreas; 1992; 7(1):87-97. PubMed ID: 1313559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic vasoactive intestinal polypeptide-secreting tumor: report of a case.
    Sheu HW; Chou SY; Yang KC; Kao CR; Yang TL; Shih CC
    Taiwan Yi Xue Hui Za Zhi; 1989 Sep; 88(9):931-5. PubMed ID: 2559939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VIPoma with expression of both VIP and VPAC1 receptors in a patient with WDHA syndrome.
    Nakayama S; Yokote T; Kobayashi K; Hirata Y; Hiraiwa T; Komoto I; Miyakoshi K; Yamakawa Y; Takubo T; Tsuji M; Imamura M; Hanafusa T
    Endocrine; 2009 Apr; 35(2):143-6. PubMed ID: 19184565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case report of vasoactive intestinal Peptide tumors].
    Zhag SL; Zhao GF; Hao RF; Zheng HY
    Ai Zheng; 2007 Sep; 26(9):1039-40. PubMed ID: 17927869
    [No Abstract]   [Full Text] [Related]  

  • 9. Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis.
    O'Brien TD; Butler AE; Roche PC; Johnson KH; Butler PC
    Diabetes; 1994 Feb; 43(2):329-36. PubMed ID: 8288058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of vasoactive intestinal peptide-secreting tumor (VIPoma) arising from MEN1 inactivation which recurred 15 years after the initial resection.
    Sakurai M; Wakabayashi T; Kondo Y; Ikeda E; Watanabe K; Takei A; Okazaki H; Okada K; Ebihara K; Kakiuchi N; Ogawa S; Fukushima N; Ishibashi S
    Endocr J; 2023 Jun; 70(6):573-579. PubMed ID: 36889692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal polypeptide-secreting tumours: biology and therapy.
    Park SK; O'Dorisio MS; O'Dorisio TM
    Baillieres Clin Gastroenterol; 1996 Dec; 10(4):673-96. PubMed ID: 9113317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review.
    Schizas D; Mastoraki A; Bagias G; Patras R; Moris D; Lazaridis II; Arkadopoulos N; Felekouras E
    J BUON; 2019; 24(2):415-423. PubMed ID: 31127985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical investigation of insulinomas for islet amyloid polypeptide and insulin: evidence for differential synthesis and storage.
    Williams AJ; Coates PJ; Lowe DG; McLean C; Gale EA
    Histopathology; 1992 Sep; 21(3):215-23. PubMed ID: 1356906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of vasoactive intestinal peptide-secreting-tumors: one case report and 15 years review in China].
    Li JT; Peng SY; Liu YB; Fang HQ; Wu YL; Wang XB; Tang Z; Qian HR; Ji C
    Zhonghua Wai Ke Za Zhi; 2004 May; 42(9):524-7. PubMed ID: 15196363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male.
    Abu-Zaid A; Azzam A; Abudan Z; Algouhi A; Almana H; Amin T
    Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):109-15. PubMed ID: 24785507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vipomas].
    Dupont C
    Ann Med Interne (Paris); 1984; 135(5):400-2. PubMed ID: 6091517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pancreatic VIPoma. Report of one case].
    Urdangarin A; Iñiguez G; Benavides C; Castillo C; Castro A; Castillos I; Corredoira Y; Soto N
    Rev Med Chil; 2010 Jul; 138(7):841-6. PubMed ID: 21043079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of VIPoma in China: (case report and 31 cases review) diagnosis and treatment of VIPoma.
    Peng SY; Li JT; Liu YB; Fang HQ; Wu YL; Peng CH; Wang XB; Qian HR
    Pancreas; 2004 Jan; 28(1):93-7. PubMed ID: 14707737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypokalemic rhabdomyolysis due to watery diarrhea, hypokalemia, achlorhydria (WDHA) syndrome caused by vipoma.
    Kibria R; Ahmed S; Ali SA; Barde CJ
    South Med J; 2009 Jul; 102(7):761-4. PubMed ID: 19488018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paralytic ileus as an initial manifestation of malignant VIPoma of the pancreas--case report with review of the literature].
    Koberstein B; Eysselein VE; Balzer K; Müller MK; Eberlein G; Singer MV; Willemer S; Adler G; Goebell H
    Z Gastroenterol; 1990 Jun; 28(6):295-301. PubMed ID: 1978446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.